News from wuxi pharmatech (cayman) inc. A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle.

Latest

Jan 08, 2016, 08:00 ET WuXi AppTec Plans $120 Million Investment in New Integrated Biologics Solution Center to Expedite Biologics Development from Ideas to Clinic

WuXi AppTec Co. Ltd. (WuXi), a leading open-access R&D capability and technology platform company serving the global pharmaceutical, biotechnology,...

Dec 16, 2015, 02:40 ET WuXi and AstraZeneca Form Strategic Alliance to Expedite Development of AstraZeneca's Innovative Biologics Portfolio in China

WuXi AppTec (WuXi), a leading open-access R&D capability and technology platform company serving the global pharmaceutical, biotechnology, and...

Dec 13, 2015, 06:00 ET WuXi PharmaTech Presents 2015 Life Science and Chemistry Awards

WuXi PharmaTech (Cayman) Inc., a leading open-access R&D capability and technology platform company serving the pharmaceutical, biotechnology and...

Dec 10, 2015, 04:45 ET WuXi PharmaTech (Cayman) Inc. Announces Completion of Going Private Transaction

WuXi PharmaTech (Cayman) Inc. (NYSE: WX), a leading open-access R&D capability and technology platform company serving the pharmaceutical,...

Dec 07, 2015, 08:00 ET Dr. Ge Li Receives Executive of the Year Award from SCRIP

WuXi PharmaTech (Cayman) Inc. (NYSE: WX), a leading open-access R&D capability and technology platform company serving the pharmaceutical,...

Nov 24, 2015, 10:00 ET WuXi PharmaTech Announces Shareholders' Approval of Merger Agreement

WuXi PharmaTech (Cayman) Inc. ("WuXi" or the "Company") (NYSE: WX), a leading open-access R&D capability and technology platform company serving the...

Nov 11, 2015, 12:01 ET ISS and Glass Lewis Recommend that WuXi PharmaTech Shareholders Vote "FOR" the Proposed Going-Private Transaction

WuXi PharmaTech (Cayman) Inc. ("WuXi" or the "Company") (NYSE: WX), a leading open-access R&D capability and technology platform company serving the...

Nov 10, 2015, 04:30 ET WuXi PharmaTech and Lilly Announce Strategic Collaboration to Develop Novel Therapeutic in China

WuXi PharmaTech (Cayman) Inc. (NYSE: WX) and Eli Lilly and Company (NYSE: LLY) today announced that they have entered into a strategic collaboration...

Nov 05, 2015, 03:17 ET WuXi PharmaTech Congratulates Novira Therapeutics

WuXi PharmaTech (Cayman) Inc. (NYSE: WX), a leading open-access R&D capability and technology platform company serving the pharmaceutical,...

Oct 29, 2015, 10:00 ET Gilead Sciences and WuXi PharmaTech Announce Collaboration for a Dedicated Analytical and Stability Testing Facility

Gilead Sciences, Inc., and WuXi PharmaTech (Cayman) Inc. (NYSE: WX), today announced that they have entered into a strategic partnership to conduct...

Oct 23, 2015, 08:00 ET WuXi PharmaTech Launches Medical Device Testing Services in China

WuXi PharmaTech (Cayman) Inc. (NYSE: WX), a leading open-access R&D capability and technology platform company serving the pharmaceutical,...

Oct 20, 2015, 10:00 ET WuXi PharmaTech (Cayman) Inc. Announces Extraordinary General Meeting of Shareholders

WuXi PharmaTech (Cayman) Inc. (NYSE: WX), a leading open-access R&D capability and technology platform company serving the pharmaceutical,...

Oct 19, 2015, 08:00 ET Dr. Peter Schultz, CEO of The Scripps Research Institute, Visits WuXi AppTec Headquarters in Shanghai

WuXi PharmaTech (Cayman) Inc. (NYSE: WX), a leading open-access R&D capability and technology platform company serving the pharmaceutical,...

Oct 16, 2015, 08:00 ET WuXi PharmaTech Receives 2015 Asian CRO Company of the Year Award from Frost & Sullivan

WuXi PharmaTech (Cayman) Inc. (NYSE: WX), a leading open-access R&D capability and technology platform company serving the pharmaceutical,...

Oct 13, 2015, 08:00 ET WuXi PharmaTech Launches Mobile OncoWuXi, the World's First App for Accessing Oncology Models

WuXi PharmaTech (Cayman) Inc. (NYSE: WX), a leading open-access R&D capability and technology platform company serving the pharmaceutical,...

Sep 17, 2015, 08:00 ET WuXi PharmaTech Receives 2015 Open-Access R&D Technology Leadership Award from Frost & Sullivan

WuXi PharmaTech (Cayman) Inc. (NYSE: WX), a leading open-access R&D capability and technology platform company serving the pharmaceutical,...

Aug 27, 2015, 08:00 ET WuXi PharmaTech's STA Subsidiary Receives First Approval from Japanese Regulatory Authorities

WuXi PharmaTech (Cayman) Inc. (NYSE: WX), a leading open-access R&D capability and technology platform company serving the pharmaceutical,...

Aug 25, 2015, 10:00 ET WuXi PharmaTech to Be Exclusive Supplier of Laboratory Testing Services to Lee's Pharm

WuXi PharmaTech (Cayman) Inc. (NYSE: WX), a leading open-access R&D capability and technology platform company serving the pharmaceutical,...

Aug 14, 2015, 04:00 ET Wuxi Pharmatech Enters Into Definitive Merger Agreement

WuXi PharmaTech (Cayman) Inc. ("WuXi" or the "Company") (NYSE: WX), a leading open-access R&D capability and technology platform company serving the...

Jul 10, 2015, 08:18 ET WuXi PharmaTech's China-Based Small-Molecule Manufacturing Subsidiary, STA, Enters into Private Placement Agreement

WuXi PharmaTech (Cayman) Inc. (NYSE: WX), a leading open-access R&D capability and technology platform company serving the pharmaceutical,...

Jun 04, 2015, 08:00 ET WuXi AppTec Partners with Fudan University and the Collaborative Innovation Center of Genetics and Development

WuXi AppTec today announced a partnership with Fudan University to bring WuXi NextCODE's world-leading population human genomics database system and...

May 21, 2015, 07:00 ET Fosun Pharma, HOPU Investments, CEL Healthcare Fund, and WuXi PharmaTech to Jointly Acquire U.S. Innovative Biotechnology Company Ambrx

A consortium ("the Consortium") consisting of entities affiliated with Shanghai Fosun Pharmaceutical Group, HOPU Investments, China Everbright...

May 13, 2015, 08:00 ET WuXi PharmaTech Announces Formation of a Special Committee to Evaluate Non-Binding Proposal

WuXi PharmaTech (Cayman) Inc. ("WuXi" or the "Company") (NYSE:WX), a leading global contract R&D services provider, today announced that, in response ...

May 13, 2015, 04:30 ET WuXi PharmaTech Announces First-Quarter 2015 Results

WuXi PharmaTech (Cayman) Inc. (NYSE: WX), a leading open-access R&D capability and technology platform company serving the pharmaceutical,...

Apr 30, 2015, 07:00 ET WuXi PharmaTech Announces Receipt of Proposal

WuXi PharmaTech (Cayman) Inc. ("WuXi" or the "Company") (NYSE:WX), a leading global contract R&D services provider, today announced that its board of ...